A detailed history of Cribstone Capital Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Cribstone Capital Management, LLC holds 800 shares of MRNA stock, worth $52,600. This represents 0.08% of its overall portfolio holdings.

Number of Shares
800
Previous 800 -0.0%
Holding current value
$52,600
Previous $95,000 50.53%
% of portfolio
0.08%
Previous 0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

BUY
$225.82 - $368.51 $180,656 - $294,808
800 New
800 $203,000
Q1 2021

Apr 23, 2021

SELL
$109.18 - $185.98 $3,275 - $5,579
-30 Closed
0 $0
Q1 2020

Apr 21, 2020

BUY
$17.78 - $31.58 $533 - $947
30 New
30 $1,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Cribstone Capital Management, LLC Portfolio

Follow Cribstone Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cribstone Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cribstone Capital Management, LLC with notifications on news.